D
Knight Therapeutics Inc. GUD.TO
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 11.10% -4.46% 26.88% 11.33% 4.36%
Total Other Revenue -- -- -- -- --
Total Revenue 11.10% -4.46% 26.88% 11.33% 4.36%
Cost of Revenue 28.20% 11.32% 37.37% 12.45% -9.65%
Gross Profit -6.34% -21.45% 14.62% 10.17% 23.95%
SG&A Expenses 22.78% 5.92% 30.02% 8.93% 13.22%
Depreciation & Amortization -9.09% -18.14% -7.05% -4.24% 1.66%
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 20.56% 4.76% 30.61% 8.70% -0.67%
Operating Income -180.74% -295.54% -3,366.39% 238.68% 4,110.01%
Income Before Tax -2,265.11% 94.75% 129.27% -93.28% 230.23%
Income Tax Expenses -211.30% 6.56% -52.22% 174.55% 260.10%
Earnings from Continuing Operations -542.81% 145.15% 142.89% -99.13% -203.61%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -542.81% 145.15% 142.89% -99.13% -203.61%
EBIT -180.74% -295.54% -3,366.39% 238.68% 4,110.01%
EBITDA -52.58% -62.73% -20.19% 11.55% 43.93%
EPS Basic -554.29% 145.95% 144.26% -99.11% -211.11%
Normalized Basic EPS -1,642.86% -100.45% 645.79% -107.27% 6.67%
EPS Diluted -543.84% 141.74% 140.76% -99.11% -215.87%
Normalized Diluted EPS -1,642.86% -100.45% 642.99% -107.27% 6.67%
Average Basic Shares Outstanding -1.68% -1.51% -3.07% -4.82% -6.59%
Average Diluted Shares Outstanding -1.68% -1.08% -2.68% -5.05% -6.76%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --